A Delphi-Based Consensus Statement on the Management of Anticoagulated Patients With Botulinum Toxin for Limb Spasticity.

MLA

Boulias, Chris, et al. “A Delphi-Based Consensus Statement on the Management of Anticoagulated Patients With Botulinum Toxin for Limb Spasticity.” Archives of Physical Medicine & Rehabilitation, vol. 99, no. 11, Nov. 2018, pp. 2183–89. EBSCOhost, https://doi.org/10.1016/j.apmr.2018.04.023.

APA

Boulias, C., Ismail, F., Phadke, C. P., Bagg, S., Bureau, I., Charest, S., Chen, R., Cheng, A., Ethans, K., Fink, M., Finlayson, H., Gulasingam, S., Guo, M., Haziza, M., Hosseini, H., Khan, O., Lang, M., Lapp, T., Leckey, R., & Li Pi Shan, R. (2018). A Delphi-Based Consensus Statement on the Management of Anticoagulated Patients With Botulinum Toxin for Limb Spasticity. Archives of Physical Medicine & Rehabilitation, 99(11), 2183–2189. https://doi.org/10.1016/j.apmr.2018.04.023

Chicago

Boulias, Chris, Farooq Ismail, Chetan P. Phadke, Stephen Bagg, Isabelle Bureau, Stephane Charest, Robert Chen, et al. 2018. “A Delphi-Based Consensus Statement on the Management of Anticoagulated Patients With Botulinum Toxin for Limb Spasticity.” Archives of Physical Medicine & Rehabilitation 99 (11): 2183–89. doi:10.1016/j.apmr.2018.04.023.